Copy Link Print Information

Moxetumomab

Customer Review

Based on 1 Customer Validation

Moxetumomab is a CD22-targeting monoclonal antibody that forms the component of Moxetumomab Pasudotox, a recombinant CD22-targeting immunotoxin. Moxetumomab binds to CD22 on malignant B cells and delivers the PE38 toxin domain to tumor cells. Moxetumomab can be used in research on relapsed or refractory hairy cell leukemia.

For research use only. We do not sell to patients.

  • Purity: 99.77%
  • CAS No.: 1622075-65-3
  • Molecular Weight:146.14 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Moxetumomab
  • Experimental Validation Results for Moxetumomab
  • Experimental Validation Results for Moxetumomab
  • Moxetumomab Chemical Structure
    Moxetumomab Chemical Structure
CAS No.: 1622075-65-3
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Moxetumomab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    IgG1-kappa

  • 1/16

    Immobilized Siglec-2/CD22 Protein, Human (512a.a, HEK293, His, HY-P73648) can bind Moxetumomab. The EC50 for this effect is 7.491 ng/mL.

  • 1/16

    Flow Cytometry analysis of Raji cells labelling Siglec-2/CD22 (red) with Moxetumomab (anti-Siglec-2/CD22) (HY-P99034). Goat Anti-Human IgG (Alexa Fluor 488) (HY-P83776) at a dilution of 1/1000 was used as the secondary antibody. Blue-Human IgG1 kappa (HY-P99001). Black-Unlabelled control, cells without incubation with primary antibody.

  • Moxetumomab Chemical Structure
    1/16
  • Moxetumomab
  • Immobilized Siglec-2/CD22 Protein, Human (512a.a, HEK293, His, HY-P73648) can bind Moxetumomab. The EC50 for this effect is 7.491 ng/mL.
  • Flow Cytometry analysis of Raji cells labelling Siglec-2/CD22 (red) with Moxetumomab (anti-Siglec-2/CD22) (HY-P99034). Goat Anti-Human IgG (Alexa Fluor 488) (HY-P83776) at a dilution of 1/1000 was used as the secondary antibody. Blue-Human IgG1 kappa (HY-P99001). Black-Unlabelled control, cells without incubation with primary antibody.
  • IgG1-kappa